Figure 1 |
Factors That Predispose Patients to Fungal Infection.
|
Figure 2 |
Immune System Post-HSCT.
|
Figure 3a |
Significant Risk Factors for Candidemia in HSCT Recipients.
|
Figure 3b |
Significant Risk Factors for Aspergillosis in HSCT Recipients.
|
Figure 4 |
Time Course of Infection After HSCT.
|
Figure 5 |
Frequency of Candidemia and Aspergillosis After HSCT.
|
Figure 6 |
Diagnostic Radiology for Aspergillosis.
|
Figure 7 |
Diagnostic Radiology for Candidiasis.
|
Figure 8 |
Microscopic Appearance of Invasive Fungal Infection.
|
Figure 9 |
Influence of Fluconazole Prophylaxis on Rates of Fungal Infection.
|
Figure 10 |
The Concept of Preemptive Therapy.
|